Press Release
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
October 30, 2025
Read More at Our Investor Site
Because we’re making headlines
We do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Latest Press Releases
Press Release
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
October 28, 2025
Read More at Our Investor SitePress Release
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
October 23, 2025
Read More at Our Investor Site
